• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

ImmunoGen - Articles and news items

ImmunoGen and Merck collaborate for ovarian cancer trial

Industry news / 5 February 2016 / Victoria White

The companies are to are to assess ImmunoGen’s mirvetuximab soravtansine in combination with Merck’s Keytruda (pembrolizumab) in FRα-positive ovarian cancer…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +